Evidence map›Paper›PMID 21119071›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2011

Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States.

Nicolien T van Ravesteyn, Clyde B Schechter, Aimee M Near, Eveline A M Heijnsdijk, Michael A Stoto, Gerrit Draisma, Harry J de Koning, Jeanne S Mandelblatt

Open access · greenAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Simulation models for socioeconomic inequalities in health: a systematic review.International journal of environmental research and public health · 2013
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Population simulation modeling of disparities in US breast cancer mortality.Journal of the National Cancer Institute. Monographs · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Structure, Function, and Applications of the Georgetown-Einstein (GE) Breast Cancer Simulation Model.Medical decision making : an international journal of the Society for Medical Decision Making · 2018
    Article
  17. Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia.Medical decision making : an international journal of the Society for Medical Decision Making · 2018
    Article
  18. Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.Medical decision making : an international journal of the Society for Medical Decision Making · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Nicolien T van RavesteynDepartment of Public Health, Erasmus MC Room AE-134, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. n.vanravesteyn@erasmusmc.nl
Clyde B Schechter
Aimee M Near
Eveline A M Heijnsdijk
Michael A Stoto
Gerrit Draisma
Harry J de Koning
Jeanne S Mandelblatt
Georgetown University Medical Center · USGeorgetown University · USAlbert Einstein College of Medicine · USErasmus MC · NL

Funding

Statistical Coordinating Center for the Breast Cancer Surveillance ConsortiumU01CA086076 · NCI · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI MIGLIORETTI, DIANA L · 2000 to 2011
$8.5M
IMPROVING THE QUALITY OF MAMMOGRAPHIC INTERPRETATIONU01CA063731 · NCI · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI BUIST, DIANA SM · 1994 to 2011
$6.7M
VERMONT BREAST CANCER SURVEILLANCE SYSTEMU01CA070013 · NCI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI GELLER, BERTA M · 1995 to 2011
$6.7M
UTILITY AND OUTCOMES FROM MAMMOGRAPHY IN NORTH CAROLINAU01CA070040 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI YANKASKAS, BONNIE C · 1995 to 2011
$6.4M
San Francisco Mammography Registry-A Research SourceU01CA063740 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KERLIKOWSKE, KARLA M · 1994 to 2011
$6.2M
STRATEGIC STUDIES IN BREAST CANCER SURVEILLANCEU01CA086082 · NCI · DARTMOUTH COLLEGE · PI ONEGA, TRACY · 2000 to 2011
$4.9M
REFERRAL PATTERNS AND COST ANALYSIS OF SCREENING MAMMOGRAPHY--FOLLOW-UP/BIOPSYU01CA063736 · NCI · COOPER INSTITUTE · PI CUTTER, GARY · 1994 to 2004
$2.7M
NEW MEXICO MAMMOGRAPHY PROJECTU01CA069976 · NCI · UNIVERSITY OF NEW MEXICO · PI ROSENBERG, ROBERT D · 1995 to 2005
$2.7M
OUTCOMES ACROSS THE SPECTRUM OF BREAST CANCER CAREU01CA088283 · NCI · GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · 2000 to 2010
$2.6M
Cancer Control at the Intersection of Aging ResearchK05CA096940 · NCI · GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · 2002 to 2011
$1.5M
NCI NIH HHS 2U01CA088283NCI NIH HHS K05 CA096940NCI NIH HHS KO5CA96940NCI NIH HHS U01 CA063731NCI NIH HHS U01 CA063736NCI NIH HHS U01 CA063740NCI NIH HHS U01 CA069976NCI NIH HHS U01 CA070013NCI NIH HHS U01 CA070040NCI NIH HHS U01 CA086076NCI NIH HHS U01 CA086082NCI NIH HHS U01 CA088283NCI NIH HHS U01CA63731NCI NIH HHS U01CA63736NCI NIH HHS U01CA63740NCI NIH HHS U01CA69976NCI NIH HHS U01CA70013NCI NIH HHS U01CA70040NCI NIH HHS U01CA86076NCI NIH HHS U01CA86082
6 · The paper itself

Abstract

backgroundU.S. Black women have higher breast cancer mortality rates than White women despite lower incidence. The aim of this study is to investigate how much of the mortality disparity can be attributed to racial differences in natural history, uptake of mammography screening, and use of adjuvant therapy.

methodsTwo simulation models use common national race, and age-specific data for incidence, screening and treatment dissemination, stage distributions, survival, and competing mortality from 1975 to 2010. Treatment effectiveness and mammography sensitivity are assumed to be the same for both races. We sequentially substituted Black parameters into the White model to identify parameters that drive the higher mortality for Black women in the current time period.

resultsBoth models accurately reproduced observed breast cancer incidence, stage and tumor size distributions, and breast cancer mortality for White women. The higher mortality for Black women could be attributed to differences in natural history parameters (26-44%), use of adjuvant therapy (11-19%), and uptake of mammography screening (7-8%), leaving 38% to 46% unexplained.

conclusionBlack women appear to have benefited less from cancer control advances than White women, with a greater race-related gap in the use of adjuvant therapy than screening. However, a greater portion of the disparity in mortality appears to be due to differences in natural history and undetermined factors. IMPACT: Breast cancer mortality may be reduced substantially by ensuring that Black women receive equal adjuvant treatment and screening as White women. More research on racial variation in breast cancer biology and treatment utilization is needed.

Indexed as

AdultBlack or African AmericanBreast NeoplasmsEarly Detection of CancerFemaleHumansMammographyUnited StatesWhite People

Identifiers

PMID21119071
PMCPMC3075821
OpenAlexW2127682290

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.